These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8772245)

  • 1. Laboratory diagnosis of APC-resistance in patients with lupus anticoagulant.
    Villa P; Aznar J; Jorquera JI; Casaña P
    Thromb Haemost; 1995 Dec; 74(6):1606-7. PubMed ID: 8772245
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Mowinckel MC; Wisløff F
    J Thromb Haemost; 2007 Nov; 5(11):2204-10. PubMed ID: 17958739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More on: normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant.
    Chang S
    J Thromb Haemost; 2004 Aug; 2(8):1480-1. PubMed ID: 15304065
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated protein C resistance assay as a screening test for thromboembolic disposition.
    Shizuka R; Amagai H; Kojima J; Fukumura Y; Kanda T; Kobayashi I
    J Med; 1997; 28(5-6):381-6. PubMed ID: 9604796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting APC-resistant factor V: a functional method without plasma dilution.
    Rylatt DB; Hohnen-Behrens C; Pilgrim RL; Dickeson LE; Neal M; Exner T
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):359-66. PubMed ID: 10493217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
    de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the mechanism of thrombosis by lupus anticoagulant inhibited protein C pathway].
    Wu J; Zhou Z; Xu J
    Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):470-2. PubMed ID: 11758227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical diagnosis of thrombosis and blood coagulation tests].
    Watanabe K
    Rinsho Byori; 1998 Mar; 46(3):235-44. PubMed ID: 9564763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance and lupus anticoagulant in pregnancy.
    Busowski JD; Jenkins AD; Hale EU; Busowski M; Dacus JV
    J Matern Fetal Med; 1999; 8(6):298-9. PubMed ID: 10582865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modified APC resistance test in the presence of factor V deficient plasma can be used in patients without oral anticoagulant.
    Trossaërt M; Conard J; Horellou MH; Elalamy I; Samama MM
    Thromb Haemost; 1996 Mar; 75(3):521-2. PubMed ID: 8701421
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients with venous thromboembolism have a lower APC response than controls. Should this be regarded as a continuous risk factor for venous thrombosis?
    Tirado I; Mateo J; Oliver A; Borrell M; Souto JC; Fontcuberta J
    Haematologica; 1999 May; 84(5):470-2. PubMed ID: 10329932
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perniosis and lupus anticoagulant].
    de Argila Fernández-Aurán D; Revenga Arranz F; Iglesias Díez L
    Rev Clin Esp; 1996 Jan; 196(1):24-7. PubMed ID: 8948839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.
    Rosborough TK; Shepherd MF
    Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus anticoagulants, thrombosis and the protein C system.
    Esmon NL; Smirnov MD; Safa O; Esmon CT
    Haematologica; 1999 May; 84(5):446-51. PubMed ID: 10329924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
    De Bel AV; Van der Cruyssen GA; Devreese KM
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
    Benattar N; Schved JF; Biron-Andréani C
    Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C.
    Galli M; Willems GM; Rosing J; Janssen RM; Govers-Riemslag JW; Comfurius P; Barbui T; Zwaal RF; Bevers EM
    Br J Haematol; 2005 Apr; 129(2):240-7. PubMed ID: 15813852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus anticoagulant in preeclampsia and non-proteinuria gestational hypertension in primiparous women].
    Arismendi Morillo G; Fernández-Abreu M; Alvarez L; Añez-Moreno R; Bucobo Z; Diez-Ewald M
    Invest Clin; 2000 Jun; 41(2):93-103. PubMed ID: 10961045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.